The Global Circulating Tumor Cell Market was valued at USD 9393.1 Million in 2017 and is expected to attain USD 28,399.2 Million by the end of 2023. Factors such as growing prevalence of cancer, increasing research and development activities, advances in biomedical and bioengineering technology and rise in global geriatric population are factors which will shape the global circulating tumor cell market and help it attain a CAGR of 20.32% over the forecast period of 2018-2023.
Global Circulating Tumor Cell Market – Competitive Tracking
Some of the eminent leaders of the market include
- Greiner Bio-One International GmbH
- Ikonisys Inc.
- Thermo Fisher Scientific
- STEMCELL Technologies
- SRI International
- Miltenyi Biotec
- QIAGEN Hannover (QIAGEN)
- Menarini Silicon Biosystems
- Hoffmann-La Roche Ltd
- Fluxion Biosciences, Inc.
- NanoString Technologies, Inc
- GE Healthcare
- Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation)
- Celltraffix Inc.
- Epic Lifesciences
Get Free Sample @ https://www.marketresearchfuture.com/sample_request/1362
Global Circulating Tumor Cell Market – Insights
Circulating Tumor Cells find their application in cancer diagnostics and management and growing incidences of oncology diseases boost the growth of the global circulatory tumor cells market. CTCs are used as a biomarker for early detection of cancer; they act as an indicator of treatment response and are beneficial in predicting outcomes and prognostication in cancer management.
Persistent need for treatment of various chronic diseases prompts vast investments by the pharmaceutical and biotechnology sector on research and development to develop breakthrough therapies for cancer and other chronic illnesses which is fostering the growth of the global circulating tumor cells market.
CTC tests are expensive as they combine a number of enrichment and detection steps which require various systems, assays, instruments and test kits that hinder the growth of the market.
Global Circulating Tumor Cell Market – Segments
The Global Circulating Tumor Cells Market is segmented by technology, application, end use, and region in the report.
The Global Circulating Tumor Cell Market is segmented on the basis of technology into CTC enrichment, CTC detection, and combined enrichment and separation of CTC.
Get Discount on Report @ https://www.marketresearchfuture.com/check-discount/1362
On the basis of application, the global circulating tumor cell market is segmented into clinical, research, and drug development.
By end use, the CTC market is segmented into hospitals & clinics, research & academic institutes, and diagnostic centers.
Global Circulating Tumor Cell Market – Geographical Analysis
The global circulatory tumor cell market spans across the regions of the Americas, Europe, Asia Pacific and the Middle East & Africa. Globally, the Americas account for the largest share of the circulating tumor cell market owing to the high prevalence of cancer in the region. Moreover, the Americas have a robust healthcare sector and is an early adopter of new technologies for healthcare purposes which drives the market in the region. The America market for circulating tumor cell is expected to reach USD 13,011.5 Million by the end of 2023 and expand at a CAGR of 20.56% over the forecast period.
Europe is the second largest Circulating Tumor Cell Market and is closely followed by Asia Pacific. Asia Pacific market is mushrooming in size and is expected to expand at a CAGR of 20.84% over the forecast period. The untapped markets of Asia Pacific store high growth opportunities for the global market. Rising incidences of cancer along with technological advancements favor the growth of the market in the region.
Major Table of Content
1 Report Prologue
2 Market Introduction
3 Research Methodology
4 Market Dynamics
5 Market Factor Analysis
6 Global Circulating Tumor Cell Market, by Application
7 Global Circulating Tumor Cell Market, by Technology
8 Global Circulating Tumor Cell Market, by End-User
9 Global Circulating Tumor Cell Market, by Region
10 Competitive Landscape
11 Company Profiles
13 List of Tables
14 List of Figures
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar
Pune – 411028
+1 646 845 9312